Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07194993 · ClinicalTrials.gov registry record · NA
PKU Protein Requirements
A NA study, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT07194993: Recruiting NA study, sponsored by Emory University.
NCT07194993 is a NA study that is actively recruiting participants, run by Emory University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07194993, a NA study, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The objective of this research is to determine the protein requirements based on genotype and medical food consumption in a sample of adults with Phenylketonuria (PKU) using the indicator amino acid oxidation (IAAO) method.
Primary Outcome
The rate of oxidation of tracer in the expired breath will be measured in each study day.
Interventions
- OTHER Nonradioactive stable oral isotope
- OTHER Test diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-02-16 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT07194993 shows while recruiting
NCT07194993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Nonradioactive stable oral isotope is the first listed.
NCT07194993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07194993 about?
NCT07194993 is a clinical study titled "PKU Protein Requirements". The objective of this research is to determine the protein requirements based on genotype and medical food consumption in a sample of adults with Phenylketonuria (PKU) using the indicator amino acid oxidation (IAAO) method.
What is the current status of trial NCT07194993?
This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-02-16. Estimated completion is 2027-08.
What interventions are being tested in trial NCT07194993?
The interventions under investigation include: Nonradioactive stable oral isotope (OTHER), Test diet (OTHER).
Who is sponsoring clinical trial NCT07194993?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07194993's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI